Workflow
凯龙股份(002783) - 2020 Q1 - 季度财报
KAILONGKAILONG(SZ:002783)2020-04-28 16:00

Financial Performance - The company's operating revenue for Q1 2020 was ¥172,538,049.56, a decrease of 51.98% compared to ¥359,323,966.15 in the same period last year[8] - The net profit attributable to shareholders was -¥15,858,340.20, representing a decline of 232.46% from ¥11,971,885.75 in the previous year[8] - The net cash flow from operating activities was -¥40,111,244.76, a decrease of 284.76% compared to ¥21,710,449.18 in the same period last year[8] - The basic earnings per share were -¥0.04, down 200.00% from ¥0.04 in the previous year[8] - The company's operating income significantly decreased due to the impact of the COVID-19 pandemic, with major items in the profit statement showing a substantial decline compared to the same period last year[17] - The expected net profit for the first half of 2020 is projected to be negative, ranging from -10 million to 10 million yuan, compared to a net profit of 73.2 million yuan in the same period of 2019[22] - The net profit for Q1 2020 was a loss of CNY 19,901,522.25, compared to a profit of CNY 20,850,349.87 in the previous year, indicating a significant decline[49] - The total operating costs amounted to CNY 195,131,689.54, down 42.7% from CNY 340,229,590.28 year-on-year[48] - The gross profit margin for Q1 2020 was negative, with a gross loss of CNY 15,961,692.12, compared to a gross profit of CNY 111,647,580.55 in the previous year[48] Assets and Liabilities - Total assets at the end of the reporting period were ¥4,515,197,178.87, an increase of 2.36% from ¥4,411,079,033.14 at the end of the previous year[8] - The company's total assets increased to CNY 3,463,686,146.61, up from CNY 3,245,836,953.06, reflecting a growth of 6.7%[45] - Total liabilities increased to CNY 2,292,122,127.88 from CNY 2,184,549,653.07, reflecting a rise of approximately 4.93%[40] - Total liabilities rose to CNY 1,968,626,688.26, compared to CNY 1,753,998,440.91, marking an increase of 12.2%[45] - The company's total equity stood at 2,226,529,380.07 CNY, reflecting a stable financial position[65] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 26,756[12] - The largest shareholder, Zhongjing Investment Holding Group Co., Ltd., held 14.79% of the shares, totaling 55,840,000 shares[12] - The company has committed to not transferring or entrusting the management of its shares for 36 months from the date of listing, ensuring stability in shareholding[21] - The company has a commitment to not reduce shareholdings for two years after the lock-up period ends, indicating a focus on long-term stability[21] Government Support and Subsidies - The company received government subsidies amounting to ¥2,968,549.60 during the reporting period[9] Impact of COVID-19 - The company anticipates that the COVID-19 pandemic will continue to adversely affect normal production and operations due to strict epidemic prevention measures, limiting logistics and personnel movement[22] - The impact of the pandemic on the company's operations is currently difficult to estimate accurately, which may affect the reliability of the performance forecast[22] - The company is aware of the investment risks associated with the ongoing pandemic and has advised investors to exercise caution[22] - The company has not yet completed the performance commitments due to the pandemic's impact, and further plans will be developed accordingly[21] Cash Flow and Investments - Cash flow from operating activities shows a net outflow of -¥40,111,244.76, compared to a net inflow of ¥21,710,449.18 in the previous period[57] - Cash flow from investing activities results in a net outflow of -¥2,921,692.68, compared to a significant outflow of -¥589,285,953.53 in the previous period[57] - Cash flow from financing activities yields a net inflow of ¥130,227,584.28, down from ¥213,702,212.55 in the previous period[58] - The ending cash and cash equivalents balance is ¥608,033,473.23, compared to ¥777,713,499.01 at the end of the previous period[58] Research and Development - The company recorded a significant increase in research and development expenses, totaling CNY 4,700,581.11, compared to CNY 10,605,642.24 in the previous year, indicating a focus on innovation despite financial losses[48] - Research and development expenses for the current period are ¥1,230,984.38, significantly lower than ¥5,732,004.97 in the previous period[52] Corporate Governance - The company has implemented measures to improve its corporate governance structure and internal control systems[20] - The company is actively working to enhance its management level in accordance with relevant laws and regulations[20] - The company has reported that all commitments made to minority shareholders have been fulfilled as scheduled[21] Financial Management - The total amount of entrusted financial management reached 24,900,000 RMB, with an unexpired balance of 11,700,000 RMB[26] - The company invested 7,600,000 RMB in bank financial products from its own funds, with an unexpired balance of 3,200,000 RMB[26] - The annualized return on bank financial products from self-owned funds was 3.00%, with a total return of 31.08 RMB[28] - The company reported a total of 500,000 RMB in entrusted financial management from raised funds, with an annualized return of 3.25%[29] - The company has no overdue amounts in its entrusted financial management[26] - The total amount of entrusted financial management from self-owned funds was 700,000 RMB, with a full recovery[26] - The company has not encountered any expected inability to recover principal in entrusted financial management[30] - The total amount of bank financial products from raised funds was 16,600,000 RMB, with an unexpired balance of 8,500,000 RMB[26] - The company has a total of 24,900,000 RMB in entrusted financial management, with no significant risks reported[29] Audit and Compliance - The company has not undergone an audit for the first quarter report[69] - The company has implemented new revenue and leasing standards starting from 2020, which may impact future financial reporting[62]